Eckler Matthew Joseph
Reporting owner on Forms 3, 4 and 5, CIK 2156044.
Eckler Matthew Joseph reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-05.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. CIK 1699382 | director | 1 | 2026-10-05 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. Stock Option (right to buy), derivative | 2026-10-01 | A granted | +84,000 | $0 | 84,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0002156044-26-000004 | PMV Pharmaceuticals, Inc. | 2026-10-05 | ||
| Form 3 0002156044-26-000002 | PMV Pharmaceuticals, Inc. | 2026-10-05 |